Search research articles
Contact Us
Filters
Showing results (101-110 of 143) with videos related to
Page
of 15
Sort By:
Expert Opinion on Investigational Drugs
|
July 5, 2005
Molecular mechanisms underlying the role of nitric oxide in the cardiovascular system
J C Stoclet, E Troncy, B Muller, et al.
European Journal of Pharmacology
|
August 12, 1999
The inducible nitric oxide synthase in vascular and cardiac tissue
J C Stoclet, B Muller, K György, et al.
British Journal of Pharmacology
|
November 1, 1993
Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine
M Tschöpl, R C Miller, J Pelton, et al.
Biochemical Pharmacology
|
June 15, 1987
Comparative effects of calmodulin inhibitors on calmodulin's hydrophobic sites and on the activation of cyclic nucleotide phosphodiesterase by calmodulin
P Schaeffer, C Luginer, A Follenius-Wund, et al.
Biochimica Et Biophysica Acta
|
February 11, 1997
Nitric oxide generation from extracellularly applied NG-hydroxy-L-arginine in LPS-activated RAW 264 macrophages
P Vetrovsky, A L Kleschyov, G Entlicher, et al.
British Journal of Pharmacology
|
September 14, 1999
Triggering role of nitric oxide in the delayed protective effect of monophosphoryl lipid A in rat heart
K György, B Muller, A Vegh, et al.
The American Journal of Physiology
|
January 14, 1999
Mechanism of Ca2+ release and entry during contraction elicited by norepinephrine in rat resistance arteries
G J Lagaud, V Randriamboavonjy, G Roul, et al.
Biochemical Pharmacology
|
May 15, 1986
Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta
C Lugnier, P Schoeffter, A Le Bec, et al.
British Journal of Pharmacology
|
June 1, 1997
Characterization of endothelium-derived relaxing factors released by bradykinin in human resistance arteries
P Ohlmann, M C Martínez, F Schneider, et al.
Physiological Research
|
December 14, 2004
Diaphorase can metabolize some vasorelaxants to NO and eliminate NO scavenging effect of 2-phenyl-4,4,5,5,-tetramethylimidazoline-1-oxyl-3-oxide (PTIO)
P Bartík, K Chalupský, L Vavruska, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 143) with videos related to
Sort By:
Page
of 15
Expert Opinion on Investigational Drugs
|
July 5, 2005
Molecular mechanisms underlying the role of nitric oxide in the cardiovascular system
J C Stoclet, E Troncy, B Muller, et al.
European Journal of Pharmacology
|
August 12, 1999
The inducible nitric oxide synthase in vascular and cardiac tissue
J C Stoclet, B Muller, K György, et al.
British Journal of Pharmacology
|
November 1, 1993
Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine
M Tschöpl, R C Miller, J Pelton, et al.
Biochemical Pharmacology
|
June 15, 1987
Comparative effects of calmodulin inhibitors on calmodulin's hydrophobic sites and on the activation of cyclic nucleotide phosphodiesterase by calmodulin
P Schaeffer, C Luginer, A Follenius-Wund, et al.
Biochimica Et Biophysica Acta
|
February 11, 1997
Nitric oxide generation from extracellularly applied NG-hydroxy-L-arginine in LPS-activated RAW 264 macrophages
P Vetrovsky, A L Kleschyov, G Entlicher, et al.
British Journal of Pharmacology
|
September 14, 1999
Triggering role of nitric oxide in the delayed protective effect of monophosphoryl lipid A in rat heart
K György, B Muller, A Vegh, et al.
The American Journal of Physiology
|
January 14, 1999
Mechanism of Ca2+ release and entry during contraction elicited by norepinephrine in rat resistance arteries
G J Lagaud, V Randriamboavonjy, G Roul, et al.
Biochemical Pharmacology
|
May 15, 1986
Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta
C Lugnier, P Schoeffter, A Le Bec, et al.
British Journal of Pharmacology
|
June 1, 1997
Characterization of endothelium-derived relaxing factors released by bradykinin in human resistance arteries
P Ohlmann, M C Martínez, F Schneider, et al.
Physiological Research
|
December 14, 2004
Diaphorase can metabolize some vasorelaxants to NO and eliminate NO scavenging effect of 2-phenyl-4,4,5,5,-tetramethylimidazoline-1-oxyl-3-oxide (PTIO)
P Bartík, K Chalupský, L Vavruska, et al.
Page
of 15